CytoDyn Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: CytoDyn Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q4 2024.
CytoDyn Inc. Operating Income (Loss) for the quarter ending November 30, 2024 was -$3.71M, a 9.09% decline year-over-year.
CytoDyn Inc. Operating Income (Loss) for the twelve months ending November 30, 2024 was $8.68M.
CytoDyn Inc. annual Operating Income (Loss) for 2023 was -$18.1M, a 55.5% increase from 2022.
CytoDyn Inc. annual Operating Income (Loss) for 2022 was -$40.6M, a 72.1% increase from 2021.
CytoDyn Inc. annual Operating Income (Loss) for 2021 was -$145M, a 39% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2024	$8.68M	-$3.71M	-$309K	-9.09%	Sep 1, 2024	Nov 30, 2024	10-Q	2025-01-14
Q3 2024	$8.99M	$22.4M	+$27M		Jun 1, 2024	Aug 31, 2024	10-Q	2024-10-15
Q2 2024	-$18.1M	-$6.63M	-$2.85M	-75.5%	Mar 1, 2024	May 31, 2024	10-K	2024-08-15
Q1 2024	-$15.2M	-$3.41M	+$507K	+12.9%	Dec 1, 2023	Feb 29, 2024	10-Q	2024-04-15
Q4 2023	-$15.7M	-$3.4M	+$19.8M	+85.3%	Sep 1, 2023	Nov 30, 2023	10-Q	2025-01-14
Q3 2023	-$35.5M	-$4.61M	+$5.1M	+52.5%	Jun 1, 2023	Aug 31, 2023	10-Q	2024-10-15
Q2 2023	-$40.6M	-$3.78M	+$75.3M	+95.2%	Mar 1, 2023	May 31, 2023	10-K	2024-08-15
Q1 2023	-$116M	-$3.92M	+$15.5M	+79.8%	Dec 1, 2022	Feb 28, 2023	10-Q	2024-04-15
Q4 2022	-$131M	-$23.2M	+$2.16M	+8.53%	Sep 1, 2022	Nov 30, 2022	10-Q	2024-01-16
Q3 2022	-$133M	-$9.71M	+$11.9M	+55.1%	Jun 1, 2022	Aug 31, 2022	10-Q	2023-10-23
Q2 2022	-$145M	-$79M	-$55.3M	-233%	Mar 1, 2022	May 31, 2022	10-K	2023-09-14
Q1 2022	-$90.1M	-$19.4M	+$11.4M	+37%	Dec 1, 2021	Feb 28, 2022	10-Q	2023-04-10
Q4 2021	-$101M	-$25.3M	-$819K	-3.34%	Sep 1, 2021	Nov 30, 2021	10-Q	2023-01-09
Q3 2021	-$101M	-$21.6M	+$3.93M	+15.4%	Jun 1, 2021	Aug 31, 2021	10-Q/A	2022-10-13
Q2 2021	-$105M	-$23.7M	+$4.08M	+14.7%	Mar 1, 2021	May 31, 2021	10-K	2022-08-15
Q1 2021	-$109M	-$30.8M	-$8.71M	-39.5%	Dec 1, 2020	Feb 28, 2021	10-Q	2022-04-11
Q4 2020	-$100M	-$24.5M	-$12.4M	-102%	Sep 1, 2020	Nov 30, 2020	10-Q	2022-01-10
Q3 2020	-$87.6M	-$25.6M	-$12.9M	-102%	Jun 1, 2020	Aug 31, 2020	10-Q	2021-10-12
Q2 2020	-$74.6M	-$27.8M	-$14M	-102%	Mar 1, 2020	May 31, 2020	10-K	2022-08-15
Q1 2020	-$60.6M	-$22.1M	-$9.2M	-71.5%	Dec 1, 2019	Feb 29, 2020	10-Q	2021-04-14
Q4 2019	-$51.4M	-$12.1M	+$3.57M	+22.7%	Sep 1, 2019	Nov 30, 2019	10-Q	2021-01-08
Q3 2019	-$55M	-$12.6M	+$857K	+6.35%	Jun 1, 2019	Aug 31, 2019	10-Q	2020-10-09
Q2 2019	-$55.9M	-$13.8M	-$2.61M	-23.3%	Mar 1, 2019	May 31, 2019	10-K	2021-07-30
Q1 2019	-$53.2M	-$12.9M	+$1.27M	+8.98%	Dec 1, 2018	Feb 28, 2019	10-Q	2020-04-09
Q4 2018	-$54.5M	-$15.7M	-$4.91M	-45.6%	Sep 1, 2018	Nov 30, 2018	10-Q	2020-01-09
Q3 2018	-$49.6M	-$13.5M	-$3.68M	-37.5%	Jun 1, 2018	Aug 31, 2018	10-Q	2019-10-08
Q2 2018	-$45.9M	-$11.2M	-$3.4M	-43.6%	Mar 1, 2018	May 31, 2018	10-K	2020-08-14
Q1 2018	-$42.5M	-$14.1M	-$6.12M	-76.4%	Dec 1, 2017	Feb 28, 2018	10-Q	2019-04-09
Q4 2017	-$36.4M	-$10.8M	-$4.62M	-75%	Sep 1, 2017	Nov 30, 2017	10-Q	2019-01-09
Q3 2017	-$31.8M	-$9.81M	-$4.45M	-83%	Jun 1, 2017	Aug 31, 2017	10-Q	2018-10-09
Q2 2017	-$27.3M	-$7.8M	-$1.22M	-18.6%	Mar 1, 2017	May 31, 2017	10-K	2019-08-14
Q1 2017	-$26.1M	-$8.02M	-$2.97M	-58.8%	Dec 1, 2016	Feb 28, 2017	10-Q	2018-04-09
Q4 2016	-$23.1M	-$6.16M	-$3.26M	-113%	Sep 1, 2016	Nov 30, 2016	10-Q	2018-01-08
Q3 2016	-$19.9M	-$5.36M	+$1.3M	+19.5%	Jun 1, 2016	Aug 31, 2016	10-Q	2017-10-10
Q2 2016	-$21.2M	-$6.58M	+$3.78M	+36.5%	Mar 1, 2016	May 31, 2016	10-K	2018-07-27
Q1 2016	-$25M	-$5.05M	-$1.76M	-53.4%	Dec 1, 2015	Feb 29, 2016	10-Q	2017-04-13
Q4 2015	-$23.2M	-$2.89M	+$97.9K	+3.27%	Sep 1, 2015	Nov 30, 2015	10-Q	2017-01-13
Q3 2015	-$23.3M	-$6.66M	-$3.7M	-125%	Jun 1, 2015	Aug 31, 2015	10-Q	2016-10-12
Q2 2015	-$19.6M	-$10.4M	-$7.72M	-293%	Mar 1, 2015	May 31, 2015	10-K	2016-07-19
Q1 2015	-$11.9M	-$3.29M	-$417K	-14.5%	Dec 1, 2014	Feb 28, 2015	10-Q	2016-04-13
Q4 2014	-$11.5M	-$2.99M	-$1.39M	-86.9%	Sep 1, 2014	Nov 30, 2014	10-Q	2016-01-11
Q3 2014	-$10.1M	-$2.95M	-$1.95M	-195%	Jun 1, 2014	Aug 31, 2014	10-Q	2015-10-09
Q2 2014	-$8.11M	-$2.64M	-$720K	-37.6%	Mar 1, 2014	May 31, 2014	10-K	2015-07-10
Q1 2014	-$7.39M	-$2.88M	-$1.25M	-77.2%	Dec 1, 2013	Feb 28, 2014	10-Q	2015-04-10
Q4 2013	-$6.14M	-$1.6M	+$42.6K	+2.59%	Sep 1, 2013	Nov 30, 2013	10-Q	2015-01-12
Q3 2013	-$6.18M	-$1M	+$1.81M	+64.4%	Jun 1, 2013	Aug 31, 2013	10-Q	2014-10-10
Q2 2013	-$7.99M	-$1.91M	+$1.48M	+43.5%	Mar 1, 2013	May 31, 2013	10-K	2014-07-10
Q1 2013	-$9.47M	-$1.62M	-$208K	-14.7%	Dec 1, 2012	Feb 28, 2013	10-Q	2014-04-11
Q4 2012	-$9.26M	-$1.64M	-$152K	-10.2%	Sep 1, 2012	Nov 30, 2012	10-Q	2014-01-13
Q3 2012	-$9.11M	-$2.81M	-$1.65M	-143%	Jun 1, 2012	Aug 31, 2012	10-Q	2013-10-15
Q2 2012	-$7.46M	-$3.39M	-$2.29M	-208%	Mar 1, 2012	May 31, 2012	10-K	2013-08-29
Q1 2012	-$5.17M	-$1.41M	-$346K	-32.4%	Dec 1, 2011	Feb 29, 2012	10-Q	2013-04-12
Q4 2011	-$4.82M	-$1.49M	-$506K	-51.4%	Sep 1, 2011	Nov 30, 2011	10-Q	2013-01-14
Q3 2011	-$4.31M	-$1.16M	-$615K	-113%	Jun 1, 2011	Aug 31, 2011	10-Q/A	2012-11-08
Q2 2011	-$3.7M	-$1.1M			Mar 1, 2011	May 31, 2011	10-K	2012-08-22
Q1 2011		-$1.07M			Dec 1, 2010	Feb 28, 2011	10-Q	2012-04-16
Q4 2010		-$985K			Sep 1, 2010	Nov 30, 2010	10-Q	2012-01-17
Q3 2010		-$544K			Jun 1, 2010	Aug 31, 2010	10-Q/A	2011-11-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.